Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jasper Therapeutics, Inc.

Clinical trials sponsored by Jasper Therapeutics, Inc., explained in plain language.

Jasper Therapeutics, Inc. JSPR NASDAQ

Biotech company developing therapies for blood disorders and cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Completed 1 Terminated 3

New shot could tame stubborn hives when other treatments fail

Disease control Completed

This trial tests a drug called briquilimab for adults with chronic spontaneous urticaria (CSU) — long-lasting hives and itching that don't get better with standard antihistamines or omalizumab. The study has three parts, with some participants getting the drug and others a placeb…

Phase: PHASE1, PHASE2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control

Last updated Aug 08, 2026 00:03 UTC